<DOC>
	<DOCNO>NCT00023751</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining surgery chemotherapy radiation therapy may kill tumor cell prevent recurrence cancer . PURPOSE : Phase II trial study effectiveness surgery without chemotherapy radiation therapy treat patient stage I rectal cancer .</brief_summary>
	<brief_title>Surgery With Without Chemotherapy Radiation Therapy TreatingPatients With Stage I Rectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine overall , disease-free , colostomy-free survival rate patient stage I rectal cancer treat local excision without adjuvant chemotherapy radiotherapy . - Determine local , regional , distant recurrence rate patient treat regimen . - Determine whether loco-regional recurrence local excision successfully salvage radical surgery without adjuvant therapy permanent cure patient treat regimen . - Determine whether analysis certain histological molecular marker help determine prognosis patient treat regimen . - Determine anorectal , urinary , sexual function effect patient treat regimen . - Determine non-functional treatment morbidity mortality exclusive anorectal , urinary , sexual function effect patient treat regimen . - Determine overall survival patient pathology exclusion undergo local excision . - Determine efficacy current standard detect recurrence follow-up , include office visit , blood test , proctoscopy patient treat regimen . OUTLINE : This multicenter study . All patient undergo full thickness disc excision . Patients T3 disease positive surgical margin surgery remove study . Patients T1 disease negative surgical margin surgery observe . Patients T2 disease negative surgical margin surgery receive adjuvant therapy . Beginning 42 day surgery , T2 patient receive leucovorin calcium ( CF ) IV 2 hour fluorouracil ( 5-FU ) IV bolus 1 hour infusion weekly 6 week . Beginning 2 week completion chemotherapy , patient receive chemoradiotherapy comprise radiotherapy daily 5 time week 5 week 5-FU IV continuously receive radiotherapy . Beginning 2 week completion chemoradiotherapy , patient receive CF IV 2 hour 5-FU IV bolus 1 hour infusion weekly 6 week . Chemotherapy repeat 2 week rest total 2 course . Patients follow every 3 month 2 year every 6 month 5 year .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma rectum T1 T2 physical endoscopic exams No T3 lesion clinical radiological exam Villous adenoma situ carcinoma allow without histologicalconfirmation clinical appearance cancer No multifocal disease within rectum time initial diagnosis No nonadenocarcinomatous rectal cancer anal cancer Less 4 cm great diameter Less 40 % rectal wall circumference involve Proximal margin great 8 cm dentate line No tumor fixation perirectal tissue regardless size No malignant regional lymph node distant metastases clinical exam orradiographical imaging No palpable perirectal lymph node node large 1 cm No evidence malignant perirectal lymph node endorectal ultrasound orendorectal MRI PATIENT CHARACTERISTICS : Age : 18 Performance status : CTC 02 Life expectancy : Not specify Hematopoietic : WBC least 4,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin le 1.5 time normal Renal : Creatinine le 1.8 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior concurrent malignancy within past 5 year except inactive nonmelanomatous skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : No prior surgery rectal cancer include prior attempt transanal transcoccygeal surgical excision unclear positive margin Prior incision operative biopsy colonoscopic removal allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage I rectal cancer</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>